093-050: Long-Term Eslicarbazepine Acetate Extension Study

Grants and Contracts Details

StatusFinished
Effective start/end date10/26/11 → 11/30/14

Funding

  • Sunovion Pharmaceuticals Incorporated: $2,241.00